| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | AADI BIOSCIENCE INC | 17383 W SUNSET BLVD | PACIFIC PALISADES | CA | 90272-4181 | LOS ANGELES | USA | R01FD005749 | Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015 | 000 | 4 | FDA | 7/7/2022 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $85,465 ) |
| | 2020 | 2020 | AADI BIOSCIENCE INC | 17383 W SUNSET BLVD STE A250 | PACIFIC PALISADES | CA | 90272-4181 | LOS ANGELES | USA | R01FD005749 | Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015 | 000 | 4 | FDA | 6/22/2020 | $499,631 |
| | 2020 | 2015 | AADI BIOSCIENCE INC | 17383 W SUNSET BLVD STE A250 | PACIFIC PALISADES | CA | 90272-4181 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 2 | NIH | 3/13/2020 | -$414,166 |
|
| Issue Date FY: 2019 ( Subtotal = $499,631 ) |
| | 2019 | 2019 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R01FD005749 | Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015 | 000 | 3 | FDA | 8/20/2019 | $499,631 |
|
| Issue Date FY: 2018 ( Subtotal = $499,631 ) |
| | 2018 | 2018 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R01FD005749 | Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015 | 000 | 2 | FDA | 7/31/2018 | $499,631 |
| | 2018 | 2015 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 2 | NIH | 9/12/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $668,559 ) |
| | 2017 | 2017 | AADI, LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272-1963 | LOS ANGELES | USA | R01FD005749 | Phase 2 study of ABI-009 Treatment of Advanced PEComa-IND 125669, 7/13/2015 | 000 | 1 | FDA | 7/27/2017 | $499,631 |
| | 2017 | 2015 | AADI, LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272-1963 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 2 | NIH | 7/31/2017 | $0 |
| | 2017 | 2015 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 002 | 2 | NIH | 8/11/2017 | $143,780 |
| | 2017 | 2015 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 004 | 2 | NIH | 8/16/2017 | $0 |
| | 2017 | 2013 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 001 | 1 | NIH | 8/11/2017 | $25,148 |
| | 2017 | 2013 | AADI, LLC | 1343 LUNA VISTA DR | PACIFIC PALISADES | CA | 90272-2235 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 003 | 1 | NIH | 8/14/2017 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $924,745 ) |
| | 2015 | 2015 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 2 | NIH | 8/21/2015 | $924,745 |
|
| Issue Date FY: 2014 ( Subtotal = $0 ) |
| | 2014 | 2013 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 1 | NIH | 7/22/2014 | $0 |
| | 2014 | 2012 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 001 | 1 | NIH | 7/22/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $168,928 ) |
| | 2013 | 2013 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 001 | 1 | NIH | 8/6/2013 | $168,928 |
| | 2013 | 2012 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 1 | NIH | 8/1/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $472,301 ) |
| | 2012 | 2012 | AADI LLC | 16730 CALLE DE CATALINA | PACIFIC PALISADES | CA | 90272 | LOS ANGELES | USA | R42CA171552 | Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t | 000 | 1 | NIH | 9/26/2012 | $472,301 |
|
|
